However, downregulation of miR-181a would reverse the inhibitory role of ANRIL knockdown on PC cell, which suggested that the oncogenic role of ANRIL on PC cells might be mediated by miR-181a. This evidence concerns the gene CDKN2B-AS1 and pachyonychia congenita.